Status:
COMPLETED
The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy
Lead Sponsor:
Seoul National University Hospital
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-70 years
Brief Summary
The purpose of this study is the evaluation of effect of circadian gene on sleep and other symptoms in breast cancer patients under chemotherapy.
Detailed Description
In this study, the investigators are going to examine the effect of genetic polymorphism on sleep, anxiety, depression and other cancer-related symptoms in patients with breast cancer who have started...
Eligibility Criteria
Inclusion
- Age: 18-70
- Patient with breast cancer without metastasis
- Patient received cancer surgery and medically stable
- Patient will undergo chemotherapy for the first time in life
- Patient have signed on the informed consent, and well understood the objective and procedure of this study
Exclusion
- Patient received chemotherapy or radiotherapy
- Patient had another cancer before
- Patient have metastasis
- Patient with severe medical condition
- Patient had taken psychiatric medication more than 1 month in life
- Patient worked the night shift for more than 1 month in 6 months
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT01887925
Start Date
February 1 2012
End Date
May 1 2015
Last Update
November 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Jongno-gu, South Korea, 140-013